Np mrd loader

Record Information
Version2.0
Created at2022-09-05 01:34:46 UTC
Updated at2022-09-05 01:34:46 UTC
NP-MRD IDNP0205625
Secondary Accession NumbersNone
Natural Product Identification
Common Name(2s)-2-[(2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-1-hydroxyethylidene)amino]-3-hydroxypropanoic acid
DescriptionAla-Gly-Ser, also known as a-g-S or L-ala-gly-L-ser, belongs to the class of organic compounds known as peptides. Peptides are compounds containing an amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another. Ala-Gly-Ser is a secondary metabolite. Secondary metabolites are metabolically or physiologically non-essential metabolites that may serve a role as defense or signalling molecules. In some cases they are simply molecules that arise from the incomplete metabolism of other secondary metabolites. (2s)-2-[(2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-1-hydroxyethylidene)amino]-3-hydroxypropanoic acid is found in Trypanosoma brucei. (2s)-2-[(2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-1-hydroxyethylidene)amino]-3-hydroxypropanoic acid was first documented in 2017 (PMID: 27768593). Based on a literature review a small amount of articles have been published on Ala-Gly-Ser (PMID: 35788005) (PMID: 33750140) (PMID: 32882279) (PMID: 31226655).
Structure
Thumb
Synonyms
ValueSource
a-g-SChEBI
AGSChEBI
Alanyl-glycyl-serineChEBI
L-Ala-gly-L-serChEBI
Chemical FormulaC8H15N3O5
Average Mass233.2240 Da
Monoisotopic Mass233.10117 Da
IUPAC Name(2S)-2-[(2-{[(2S)-2-amino-1-hydroxypropylidene]amino}-1-hydroxyethylidene)amino]-3-hydroxypropanoic acid
Traditional Name(2S)-2-[(2-{[(2S)-2-amino-1-hydroxypropylidene]amino}-1-hydroxyethylidene)amino]-3-hydroxypropanoic acid
CAS Registry NumberNot Available
SMILES
C[C@H](N)C(O)=NCC(O)=N[C@@H](CO)C(O)=O
InChI Identifier
InChI=1S/C8H15N3O5/c1-4(9)7(14)10-2-6(13)11-5(3-12)8(15)16/h4-5,12H,2-3,9H2,1H3,(H,10,14)(H,11,13)(H,15,16)/t4-,5-/m0/s1
InChI KeyNBTGEURICRTMGL-WHFBIAKZSA-N
Experimental Spectra
Not Available
Predicted Spectra
Spectrum TypeDescriptionDepositor IDDepositor OrganizationDepositorDeposition DateView
1D NMR13C NMR Spectrum (1D, 25 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 100 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 252 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 1000 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 50 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 200 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 75 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 300 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 101 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 400 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 126 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 500 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 151 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 600 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 176 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 700 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 201 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 800 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 226 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 900 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
Chemical Shift Submissions
Not Available
Species
Species of Origin
Species NameSourceReference
Trypanosoma bruceiLOTUS Database
Chemical Taxonomy
Description Belongs to the class of organic compounds known as peptides. Peptides are compounds containing an amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another.
KingdomOrganic compounds
Super ClassOrganic acids and derivatives
ClassCarboxylic acids and derivatives
Sub ClassAmino acids, peptides, and analogues
Direct ParentPeptides
Alternative Parents
Substituents
  • Alpha peptide
  • N-acyl-alpha-amino acid
  • N-acyl-alpha amino acid or derivatives
  • Serine or derivatives
  • Alpha-amino acid or derivatives
  • Beta-hydroxy acid
  • Hydroxy acid
  • Amino acid or derivatives
  • Amino acid
  • Carboximidic acid
  • Carboximidic acid derivative
  • Carboxylic acid
  • Monocarboxylic acid or derivatives
  • Organic 1,3-dipolar compound
  • Propargyl-type 1,3-dipolar organic compound
  • Hydrocarbon derivative
  • Amine
  • Primary aliphatic amine
  • Organic oxide
  • Organic nitrogen compound
  • Alcohol
  • Carbonyl group
  • Organic oxygen compound
  • Organonitrogen compound
  • Organooxygen compound
  • Organopnictogen compound
  • Primary alcohol
  • Primary amine
  • Aliphatic acyclic compound
Molecular FrameworkAliphatic acyclic compounds
External Descriptors
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
logP-4.2ChemAxon
pKa (Strongest Acidic)3.14ChemAxon
pKa (Strongest Basic)9.57ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count8ChemAxon
Hydrogen Donor Count5ChemAxon
Polar Surface Area148.73 ŲChemAxon
Rotatable Bond Count6ChemAxon
Refractivity53.19 m³·mol⁻¹ChemAxon
Polarizability22.46 ųChemAxon
Number of Rings0ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
HMDB IDNot Available
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FoodDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID119047
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound135103
PDB IDNot Available
ChEBI ID73350
Good Scents IDNot Available
References
General References
  1. Asakura T, Naito A: Structure of silk I (Bombyx mori silk fibroin before spinning) in the dry and hydrated states studied using (13)C solid-state NMR spectroscopy. Int J Biol Macromol. 2022 Sep 1;216:282-290. doi: 10.1016/j.ijbiomac.2022.06.192. Epub 2022 Jul 2. [PubMed:35788005 ]
  2. Donets S, Guskova O, Sommer JU: Searching for Aquamelt Behavior among Silklike Biomimetics during Fibrillation under Flow. J Phys Chem B. 2021 Apr 1;125(12):3238-3250. doi: 10.1021/acs.jpcb.1c00647. Epub 2021 Mar 22. [PubMed:33750140 ]
  3. Asakura T, Ogawa T, Naito A, Williamson MP: Chain-folded lamellar structure and dynamics of the crystalline fraction of Bombyx mori silk fibroin and of (Ala-Gly-Ser-Gly-Ala-Gly)(n) model peptides. Int J Biol Macromol. 2020 Dec 1;164:3974-3983. doi: 10.1016/j.ijbiomac.2020.08.220. Epub 2020 Aug 31. [PubMed:32882279 ]
  4. Watanabe M, Sugawara A, Noguchi Y, Hirose T, Omura S, Sunazuka T, Horie R: Jietacins, azoxy natural products, as novel NF-kappaB inhibitors: Discovery, synthesis, biological activity, and mode of action. Eur J Med Chem. 2019 Sep 15;178:636-647. doi: 10.1016/j.ejmech.2019.05.079. Epub 2019 May 29. [PubMed:31226655 ]
  5. Redko B, Tuchinsky H, Segal T, Tobi D, Luboshits G, Ashur-Fabian O, Pinhasov A, Gerlitz G, Gellerman G: Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanoma. Oncotarget. 2017 Jan 3;8(1):757-768. doi: 10.18632/oncotarget.12748. [PubMed:27768593 ]
  6. LOTUS database [Link]